Found: 12
Select item for more details and to access through your institution.
A Clinical Analysis of Anti-Programmed Death-Ligand 1 (PD-L1) Immune Checkpoint Inhibitor Treatments Combined with Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 474, doi. 10.3390/vaccines12050474
- By:
- Publication type:
- Article
Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study.
- Published in:
- Vaccines, 2021, v. 9, n. 10, p. 1122, doi. 10.3390/vaccines9101122
- By:
- Publication type:
- Article
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231222604
- By:
- Publication type:
- Article
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113278
- By:
- Publication type:
- Article
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035710
- By:
- Publication type:
- Article
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035710
- By:
- Publication type:
- Article
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 316, doi. 10.3390/cancers14020316
- By:
- Publication type:
- Article
Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 4, p. 626, doi. 10.1002/ijc.33821
- By:
- Publication type:
- Article
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 7, p. 529, doi. 10.1111/1759-7714.15212
- By:
- Publication type:
- Article
Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02357-z
- By:
- Publication type:
- Article
Feasibility and Safety of Transbronchial Lung Cryobiopsy for Diagnosis of Acute Respiratory Failure with Mechanical Ventilation in Intensive Care Unit.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 12, p. 2917, doi. 10.3390/diagnostics12122917
- By:
- Publication type:
- Article
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
- Published in:
- Targeted Oncology, 2023, v. 18, n. 2, p. 195, doi. 10.1007/s11523-023-00946-w
- By:
- Publication type:
- Article